STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LGVN Form 3 shows director reports no beneficial ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Longeveron (LGVN): A reporting person serving as a director filed an initial Form 3. The filing states no securities are beneficially owned, with Table I showing Class A Common Stock: 0 and no derivative securities listed. The date of the event requiring the statement is 10/01/2025. The submission includes a Power of Attorney, with the form signed by an attorney-in-fact.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Paletta George A. Jr.

(Last) (First) (Middle)
1951 NW 7TH AVENUE SUITE 520

(Street)
MIAMI FL 33136

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2025
3. Issuer Name and Ticker or Trading Symbol
Longeveron Inc. [ LGVN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 0(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. No securities are beneficially owned.
Remarks:
Exhibit List - Exhibit 24 Power of Attorney
/s/ Paul Lehr, attorney-in-fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Longeveron (LGVN) disclose in this Form 3?

An initial beneficial ownership statement by a director indicating no securities are beneficially owned.

How many Longeveron Class A shares were reported as owned?

Table I reports 0 shares of Class A Common Stock beneficially owned.

Were any derivative securities reported for LGVN?

No. Table II lists no derivative securities.

What is the relationship of the reporting person to Longeveron?

The reporting person is a Director.

What is the event date for this Form 3?

The date of the event requiring the statement is 10/01/2025.

Who signed the filing and under what authority?

It was signed by /s/ Paul Lehr, attorney-in-fact, with an Exhibit 24 Power of Attorney referenced.
Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Latest SEC Filings

LGVN Stock Data

13.38M
16.86M
14.83%
6.96%
5.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI